Dr. Amatruda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
480 Osborne Rd NE
Ste 220
Fridley, MN 55432Phone+1 763-786-1620Fax+1 763-780-3099
Education & Training
- California Institute of TechnologyPost-Doctoral Fellowship, Biology, Signal Transduction, 1985 - 1992
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
- UCSF Health1978 - 1981
- Yale School of MedicineClass of 1978
Certifications & Licensure
- MN State Medical License 1992 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2006 Oct 01
- Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
Publications & Presentations
PubMed
- 1662 citationsTalimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced MelanomaRobert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio, Thomas Amatruda, Neil Senzer
Journal of Clinical Oncology. 2015-05-26 - 55 citationsSerial Monitoring of Circulating Tumor Cells Predicts Outcome of Induction Biochemotherapy plus Maintenance Biotherapy for Metastatic MelanomaKazuo Koyanagi, Steven J. O'Day, Peter D. Boasberg, Michael B. Atkins, He-Jing Wang
Clinical Cancer Research. 2010-04-15 - 447 citationsPhase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastati...Neil Senzer, Howard L. Kaufman, Thomas Amatruda, Mike Nemunaitis, Tony Reid
Journal of Clinical Oncology. 2009-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: